25021-0229 Cytarabine - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

25021-0229

Brand Name:

Cytarabine

Generic Name:

Cytarabine

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intrathecal

Intravenous

Subcutaneous

Substances:

Name: CYTARABINE

Strength: 20.0

Unit: mg/mL

Packages:

Code: 25021-0229-05

Description: 5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL

Effective Date: June 1, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antimetabolite

Minor Class:

Pyrimidine Analog

Orphan Drug Designation:

Status:

In Use